Comprehensive Immunoglobulin G, A, and M Glycopeptide Profiling for Large-Scale Biomedical Research
Molecular & Cellular Proteomics · 2025-03 · 24 (3) · 100928
DOI: 10.1016/j.mcpro.2025.100928 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2025-03. Verfasst von Bianca D M van Tol und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Immunoglobulin G, Glycopeptides, Immunoglobulin M, Immunoglobulin A. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE European Research Council, Health~Holland, European Commission.
Abstract (Originalsprache)
Glycosylation of immunoglobulin G (IgG) is recognized as a key modulator of cellular effector functions. At the same time, an increasing body of evidence underlines the importance of other antibody isotypes, especially IgA and IgM, in pathophysiological conditions. Therefore, methods to efficiently study the complex interplay between isotypes, subclasses, and glycosylation of antibodies during acute and chronic states of inflammation are needed. As a solution, we present an integrated and comprehensive method combining simultaneous affinity enrichment of IgG, IgA, and IgM with a single measurement, glycopeptide-centered LC-MS analysis of all isotypes which provides protein-specific (isotype and subclass), and site-specific N- and O-glycosylation quantitation. A two-protease approach provided individual peptides for each glycosylation site, allowing unambiguous compositional assignment and relative quantitation of glycoforms on the MS1 level as well as structural confirmation and partial isomer assignment on the MS/MS level. We demonstrate that our methodology can be efficiently applied to large clinical studies revealing differences in antibody glycosylation in women during and after pregnancy, as well as between healthy donors and patients with rheumatoid arthritis. In addition, this showcased the advantages of our method in comprehensiveness and resolution of isotypes, subclasses, and glycosylation sites as well as its precision and robustness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Rheumatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: d.falck@lumc.nl.
Förderung
- HORIZON EUROPE European Research Council
- Health~Holland
- European Commission
- European Research Council
Zitieren
APA
van Tol, B. D. M., Wasynczuk, A. M., Gijze, S., Mayboroda, O. A., Nouta, J., Dolhain, R. J. E. M., Wuhrer, M., & Falck, D. (2025). Comprehensive Immunoglobulin G, A, and M Glycopeptide Profiling for Large-Scale Biomedical Research. Molecular & Cellular Proteomics, 24(3), 100928. https://doi.org/10.1016/j.mcpro.2025.100928
Vancouver
van Tol BDM, Wasynczuk AM, Gijze S, Mayboroda OA, Nouta J, Dolhain RJEM, et al. Comprehensive Immunoglobulin G, A, and M Glycopeptide Profiling for Large-Scale Biomedical Research. Molecular & Cellular Proteomics. 2025;24(3):100928. doi:10.1016/j.mcpro.2025.100928
BibTeX
@article{vanTol2025,
author = {van Tol, Bianca D M and Wasynczuk, Anna M and Gijze, Steinar and Mayboroda, Oleg A and Nouta, Jan and Dolhain, Radboud J E M and Wuhrer, Manfred and Falck, David},
title = {Comprehensive Immunoglobulin G, A, and M Glycopeptide Profiling for Large-Scale Biomedical Research},
journal = {Molecular & Cellular Proteomics},
year = {2025},
volume = {24},
number = {3},
pages = {100928},
doi = {10.1016/j.mcpro.2025.100928}
}
EUVIMED